Nurofen forced to pull pain specific products, claims it did not set out to mislead consumers

Nurofen has been forced to pull one of its major product lines after a court found it had engaged in misleading conduct, claiming its products where pain specific, when the products were in fact identical.

Nurofen Specific Pain products landscapeThe leading pain brand was forced to concede to the Federal Court that it had mislead consumers and was ordered to remove the Nurofen Specific Pain products – covering back, period, migraine and tension headaches – from shelves within three months.

“Nurofen did not set out to mislead consumers,” said a Nurofen spokeswoman. “(We have) co-operated with the ACCC in relation to these proceedings and will fully comply with the court order made today”.

This is not the first time the pain relief brand, and its parent Reckitt Benckiser, has been reprimanded for its advertising with the Therapeutic Goods Administration forcing the withdrawal of an ad which claimed “targeted relief” back in 2013.

Subscribe to keep reading

Join Mumbrella Pro to access the Mumbrella archive and read our premium analysis of everything under the media and marketing umbrella.

Subscribe

Get the latest media and marketing industry news (and views) direct to your inbox.

Sign up to the free Mumbrella newsletter now.

"*" indicates required fields

 

SUBSCRIBE

Sign up to our free daily update to get the latest in media and marketing.